What is the current valuation of the UK medical second-opinion market?

The market valuation was $252.55 Million in 2024. Read More

What is the projected market size for the UK medical second-opinion market by 2035?

The market is projected to reach $1,099.0 Million by 2035. Read More

What is the expected CAGR for the UK medical second-opinion market during the forecast period 2025 - 2035?

The expected CAGR is 14.3% during the forecast period. Read More

Which segments are driving growth in the UK medical second-opinion market?

Key segments include Cancer, Diabetes, and Cardiac Disorders, with valuations ranging from $25.0 Million to $220.0 Million. Read More

Who are the key players in the UK medical second-opinion market?

Key players include Mayo Clinic, Cleveland Clinic, and Bupa, among others. Read More

What are the primary sources of service in the UK medical second-opinion market?

The primary sources are In-House and Outsourced services, each valued at approximately $126.275 Million. Read More

What types of services are offered in the UK medical second-opinion market?

Services include Medical Condition Management, Post-Acute Care Nursing, and Medical Peer Review Services, with valuations up to $549.0 Million. Read More

How do hospitals and online physicians contribute to the UK medical second-opinion market?

Hospitals and online physicians contribute significantly, with valuations of $100.0 Million and $60.0 Million, respectively. Read More

What role do health insurance companies play in the UK medical second-opinion market?

Health insurance companies are valued at approximately $42.55 Million, indicating their involvement in the market. Read More

What is the future outlook for the UK medical second-opinion market?

The market is expected to grow substantially, reaching $1,099.0 Million by 2035, driven by increasing demand for second opinions. Read More

UK Medical Second Opinion Market

UK Medical Second Opinion Market Research Report By Application Outlook (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Respiratory Disorders, Ocular Disorders), By Source of Service Outlook (In-House, Outsourced), By Services Outlook (Medical Condition Management, Post-Acute Care Nursing, Medical Peer Review Services) and By Type Outlook (Hospitals Physicians/Specialties, Online Physicians Portal, UK Medical Second Opinion Companies, Health Insurance Companies) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

14.3%

2024 Market Size

$ 252.55 Million

2035 Market Size

$ 1,099 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/42594-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Application (USD Million)
  1. 4.1.1 Cancer
  2. 4.1.2 Diabetes
  3. 4.1.3 Cardiac Disorders
  4. 4.1.4 Neurological Disorders
  5. 4.1.5 Respiratory Disorders
  6. 4.1.6 Ocular Disorders
2. 4.2 Chemicals and Materials, BY Source of Service (USD Million)
  1. 4.2.1 In-House
  2. 4.2.2 Outsourced
3. 4.3 Chemicals and Materials, BY Services (USD Million)
  1. 4.3.1 Medical Condition Management
  2. 4.3.2 Post-Acute Care Nursing
  3. 4.3.3 Medical Peer Review Services
4. 4.4 Chemicals and Materials, BY Type (USD Million)
  1. 4.4.1 Hospitals Physicians/Specialties
  2. 4.4.2 Online Physicians Portal
  3. 4.4.3 Medical Second Opinion Companies
  4. 4.4.4 Health Insurance Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Mayo Clinic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Cleveland Clinic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johns Hopkins Medicine (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Massachusetts General Hospital (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 MD Anderson Cancer Center (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cleveland Clinic Abu Dhabi (AE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bupa (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Teladoc Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY SOURCE OF SERVICE
4. 6.4 UK MARKET ANALYSIS BY SERVICES
5. 6.5 UK MARKET ANALYSIS BY TYPE
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY SOURCE OF SERVICE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY SOURCE OF SERVICE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY SERVICES, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY SERVICES, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY SOURCE OF SERVICE, 2025-2035 (USD Million)
  3. 7.2.3 BY SERVICES, 2025-2035 (USD Million)
  4. 7.2.4 BY TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Medical Second Opinion Market Segmentation

UK Medical Second Opinion Market By Application (USD Million, 2025-2035)

Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Respiratory Disorders
Ocular Disorders

UK Medical Second Opinion Market By Source of Service (USD Million, 2025-2035)

In-House
Outsourced

UK Medical Second Opinion Market By Services (USD Million, 2025-2035)

Medical Condition Management
Post-Acute Care Nursing
Medical Peer Review Services

UK Medical Second Opinion Market By Type (USD Million, 2025-2035)

Hospitals Physicians/Specialties
Online Physicians Portal
Medical Second Opinion Companies
Health Insurance Companies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”